Genetic Analyses of Familial Tauopathies

The Frontotemporal Dementia and Related Disorders Laboratory is also involved in the identification of novel genes and genetic risk factors driving tau pathology, or the abnormal accumulation of tau protein, in patients diagnosed with progressive supranuclear palsy or corticobasal generation at autopsy. The goal is to identify novel genes for these parkinsonian syndromes using whole-genome sequencing in families.

For more information about this project and Mayo Clinic's involvement, please visit the National Institute of Neurological Disorders and Stroke.